RENO, Nev., May 26, 2005 (PRIMEZONE) -- Martin Nutraceuticals Inc. (Pink Sheets:MTNU) is pleased to announce that with the addition of Mr. Andre Poirier to the Executive Sales team, the company, along with Mr. Poirier's directive has established July 15th, 2005 as the launch date for Martin products to be available in the province of Quebec. The products being prepared are:
1) Oxygenol(tm) - The world's most power antioxidant
formula. This will be available in liquid and capsules.
2) Arithrizyme(tm) - A systemic oral enzyme formula that
helps to fight inflammatory conditions such as arthritis,
sports injuries and Fibromyalgia.
3) Maximum Slim(tm) - An all natural weight management
formula that promotes healthy fat loss.
Discussing with Mr. Poirier, the company is preparing a significant launch for the products in Quebec, one that will include a fairly aggressive marketing campaign incorporating 30 and 60-second television commercials, radio and print media, using Dr. Martin, head of Research and Development and Martin Nutraceuticals.
"Tony (Dr. Martin) is the fourth most recognizable face in the province of Quebec and to have him out there promoting the products should surely be a huge asset to the products," states Harvey Panesar, President of Martin Nutraceuticals Inc. "With Andre's (Poirier) relationships and Tony's recognition, Quebec should be a well-receptive market for us and one that we are anxious to enter."
Martin Nutraceuticals Inc. while preparing for its' North American launch has been contacted by various distribution companies for international deployment of the products.
"Interestingly, we have been contacted by various distribution companies to offer our products on an international level. It is definitely a great feeling to know that there is a larger demand and greater anticipation than we originally thought there would be," concludes Mr. Panesar
Forward Looking Statements
The management of the company, who take full responsibility for its content, prepared this press release. Statements in this news release concerning the company's business outlook or future economic performance, anticipated profitability, revenues, expenses, or other financial items; and statements concerning assumptions made or expectations as to any future events, conditions, performance or other matters, are "forward-looking statements" as that term is defined under the Federal Securities Laws. Forward-looking statements are subject to risks, uncertainties and other factors which could cause actual results to differ materially from those contained in such statements. Such risks, uncertainties and factors include, but are not limited to, future capital needs, changes and delays in product development plans and schedules, customer acceptance of new products, changes in pricing or other actions by competitors, and general economic conditions.